Phase 2: CBD safety clinical outcomes after application on normal oral mucosa
jaundice, liver dysfunction, nausea,, pain
ADVERSE REACTION, ANAPHYLACTIC REACTION, ALLERGIC REACTION
None of the subjects experienced or reported an obvious adverse reaction (irritant response or allergic reaction) on their oral mucosa. Furthermore, no anaphylactic reactions were observed in the respiratory or circulatory system and no signs of liver dysfunction were reported (e.g., nausea, vomiting, jaundice, right upper quadrant pain, or dark urine). The subjects’ vital signs and blood parameters were stable before and after the 7-day CBD intervention (